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Herpesviruses are characterized as having two distinct life cycle phases: lytic replication and latency. The
mechanisms of latency establishment and maintenance, as well as the switch from latency to lytic replication,
are poorly understood. Human gammaherpesviruses, including Epstein-Barr virus (EBV) and human herpes-
virus-8 (HHV-8), also known as Kaposi’s sarcoma-associated herpesvirus (KSHV), are associated with lym-
phoproliferative diseases and several human tumors. Unfortunately, the lack of cell lines to support efficient
de novo productive infection and restricted host ranges of EBV and HHV-8 make it difficult to explore certain
important biological questions. Murine gammaherpesvirus 68 (MHV-68, or gHV68) can establish de novo lytic
infection in a variety of cell lines and is also able to infect laboratory mice, offering an ideal model with which
to study various aspects of gammaherpesvirus infection. Here we describe in vitro studies of the mechanisms
of the switch from latency to lytic replication of MHV-68. An MHV-68 gene, rta (replication and transcription
activator), encoded primarily by open reading frame 50 (ORF50), is homologous to the rta genes of other
gammaherpesviruses, including HHV-8 and EBV. HHV-8 and EBV Rta have been shown to play central roles
in viral reactivation from latency. We first studied the kinetics of MHV-68 rta gene transcription during de novo
lytic infection. MHV-68 rta was predominantly expressed as a 2-kb immediate-early transcript. Sequence
analysis of MHV-68 rta cDNA revealed that an 866-nucleotide intron 5* of ORF50 was removed to create the
Rta ORF of 583 amino acids. To test the functions of MHV-68 Rta in reactivation, a plasmid expressing Rta
was transfected into a latently infected cell line, S11E, which was established from a B-cell lymphoma in an
MHV-68-infected mouse. Rta induced expression of viral early and late genes, lytic replication of viral DNA,
and production of infectious viral particles. We conclude that Rta alone is able to disrupt latency, activate viral
lytic replication, and drive the lytic cycle to completion. This study indicates that MHV-68 provides a valuable
model for investigating regulation of the balance between latency and lytic replication in vitro and in vivo.
Latency provides unique advantages for herpesviruses to
escape host immune surveillance and to establish lifelong per-
sistent infections. However, to maintain viral reservoirs and
transmit to other hosts, herpesviruses must be reactivated from
latency and enter the lytic replication phase to generate more
virus. The balance between viral latency and lytic replication is
therefore a critical factor that determines the outcome of in-
fection and the corresponding pathogenesis. If the balance
favors lytic replication, lytic infections of herpes simplex virus
sometimes lead to morbidity through encephalitis or visual loss
through keratoconjunctivitis (43). On the other hand, if the
balance favors viral latency, latent infection by Epstein-Barr
virus (EBV) can cause lymphoproliferative diseases (29).
The physiological signals that cause reactivation of herpes-
viruses are not well understood. The molecular mechanisms of
reactivation have been most extensively investigated in two
human gammaherpesviruses, EBV and human herpesvirus 8
(HHV-8). Most of these studies have been carried out in B-cell
lymphoma-derived cell lines harboring the latent virus. In
EBV, two viral gene products, ZEBRA and Rta, are expressed
earliest upon reactivation induced by chemical or biological
agents (21, 25, 33, 37) and activate viral promoters triggering
lytic gene expression (1–3, 5, 6, 11, 12, 14). To study the
functions of ZEBRA and Rta in reactivation, plasmids express-
ing ZEBRA and Rta were transfected into latently infected
B-cell lines to determine whether expression of viral lytic genes
and lytic replication of viral DNA were activated. ZEBRA
alone is able to activate viral lytic cycle in B cells and epithelial
cells latently infected with EBV (5, 15, 19). Rta synergizes with
ZEBRA to promote activation of viral lytic gene expression (3,
6, 27, 44), but does not always disrupt latency by itself. In
certain latently infected B-cell and epithelial cell lines, Rta can
disrupt viral latency (28, 44). ZEBRA and Rta act as transcrip-
tional activators in transient transfection assays with reporter
constructs. Moreover, ZEBRA and Rta have been shown to
stimulate expression, not only of themselves, but of each other
(8, 28, 32, 44, 45), although the levels of activation vary, de-
pending upon the experimental system used. Therefore, it has
been proposed that ZEBRA and Rta function in a cooperative
manner to activate the viral lytic cycle.
The HHV-8 homologue of EBV Rta has been shown to be
sufficient to activate expression of early and late viral lytic
genes in B-cell lines latently infected with HHV-8; however, it
has not been demonstrated whether viral lytic DNA replication
or virus production can be induced (17, 35). Upon reactivation,
HHV-8 rta is expressed as an immediate-early gene, but the
* Corresponding author. Mailing address: Department of Molecular
and Medical Pharmacology, University of California at Los Angeles,
Los Angeles, CA 90095-1735. Phone: (310) 794-5557. Fax: (310) 794-
5123. E-mail: rsun@mednet.ucla.edu.
3659
zebra homologue of HHV-8 is an early gene. Moreover,
HHV-8 ZEBRA is not able to disrupt latency (35). Although
the roles of ZEBRA and Rta in reactivation of EBV or HHV-8
have been investigated, their expression and functions during
de novo lytic infection cannot be studied, because there is no
efficient in vitro system available. In addition, the lack of an
effective animal model has made studies of gammaherpesvirus
reactivation in vivo almost impossible.
Murine gammaherpesvirus 68 (MHV-68, also referred to as
gHV68), which is phylogenetically related to HHV-8 and EBV,
offers an excellent model in which to study the mechanisms
underlying the dynamic balance between latency and lytic rep-
lication (40). In vitro cell culture systems are available to study
de novo lytic infection, latency, and reactivation of MHV-68.
Moreover, MHV-68 can establish lytic and latent infection in
laboratory mice (36), which allows us to address questions
regarding the host-virus interactions (22, 23, 30, 33). MHV-68
forms plaques on monolayers of many cell lines, making it
relatively easy to genetically manipulate the viral genome. This
also makes it possible to examine the functions of individual
viral genes in various aspects of the viral life cycle, including
reactivation.
The molecular mechanisms of MHV-68 reactivation, how-
ever, have not been previously characterized. Efforts have
been made to identify the zebra homologue in MHV-68, but
so far have not been successful. On the other hand, the rta
homologue is readily found in MHV-68 (18), and, in fact, rta
is conserved among gammaherpesviruses, including EBV,
HHV-8, herpesvirus saimiri (HVS), and bovine herpesvirus 4
(BHV-4). This led us to test the hypothesis that MHV-68 Rta
may be the central viral factor governing reactivation. In this
study, the kinetics of MHV-68 rta transcription during de
novo lytic infection were first examined. Next, the functions of
MHV-68 Rta in reactivation were studied by using a B-cell line
harboring latent MHV-68. Our results indicate that MHV-68
rta is expressed as an immediate-early gene during de novo
lytic infection and is capable of initiating viral lytic replication
in latently infected B cells.
MATERIALS AND METHODS
Viruses, cells, and plaque assays. MHV-68 was originally obtained from the
American Type Culture Collection (VR1465), and the working stocks were
grown by infecting BHK-21 cells (ATCC CCL-10) at 0.1 PFU per cell. BHK-21
cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) con-
taining 10% fetal bovine serum (FBS). S11E is a clonal cell line of S11, which was
established from a B-cell lymphoma developed in an MHV-68-infected mouse
and contains latent MHV-68 (38). S11E was cloned on the basis of a low
spontaneous reactivation frequency (13). S11E cells were cultured in RPMI 1640
medium containing 15% FBS. To infect BHK-21 cells, the viral inoculum in
DMEM was incubated with cells for 1 h with occasional swirling. The inoculum
was removed and replaced with fresh DMEM plus 10% FBS. For the experi-
ments involving cycloheximide (Sigma, St. Louis, Mo.) (see Fig. 2), cells were
treated at a concentration of 100 or 200 mg/ml 1 h prior to, during, and after viral
inoculation until they were harvested. For the experiments using phosphonoace-
tic acid (PAA) (Sigma) (Fig. 2), cells were treated at a concentration of 200
mg/ml after viral inoculation until they were harvested.
The viral titers were measured by plaque assays, using monolayers of BHK-21
cells overlaid with 1% methylcellulose (Sigma) for 5 days. The cells were fixed
and stained with 2% crystal violet in 20% ethanol. Plaques were then counted to
determine the titers. To measure the viral titers in the supernatants of trans-
fected S11E cells, the suspension cultures of cells were centrifuged twice at 450
3 g, and the supernatants were harvested for plaque assays.
RT-PCR, DNA cloning, and sequencing. For reverse transcription (RT), 0.5 mg
of 22-mer oligo(dT) and 2 mg of total RNA isolated from BHK-21 cells infected
with MHV-68 (2 PFU/cell) at 8 h postinfection were first denatured at 70°C for
10 min, immediately placed on ice, and incubated with 200 U of Superscript II
(Gibco BRL, Gaithersburg, Md.) at 42°C for 1 h. Ten percent of the product was
then amplified by PCR, with primers R3 (59-CTGAATTCGCAGCGATGGCC
TCTGACTC-39, containing an EcoRI site [underlined] and the Kozak’s se-
quence upstream of the translation initiation codon [boldface], corresponding to
nucleotide [nt] 66760) and R4 (59-GATCTAGACCGTTTATGACTCCAGGCT
G-39, containing an XbaI site [underlined] upstream of the termination codon
[boldface], corresponding to nt 69374). The RT-PCR product was reamplified by
using R3 and another primer internal to R4, R6 (59-GATATGTACCCACATG
GATGCCTGT-39, corresponding to nt 67974 to 67950). The resulting product
was cloned into the pCR2.1 T-vector (Invitrogen, Carlsbad, Calif.). The positive
colonies were selected by blue-white screening, and plasmid DNA from those
colonies was isolated for DNA sequencing with primer R7 (59-CATCTTCAGG
GTGCTGTAGGAA-39, corresponding to nt 67781 to 67760). The nucleotide
numbering is according to Virgin et al. (40), and the relative positions of the
primers to open reading frame 50 (ORF50) are indicated in Fig. 1C. To
construct an Rta expression vector, the rta genomic sequence was amplified
by PCR with primers R3 and R4 from total DNA isolated from MHV-68-
infected BHK-21 cells. The 2.6-kb PCR product was subjected to XbaI di-
gestion followed by EcoRI digestion and then cloned into a pcDNA3 vector
(Invitrogen) containing the cytomegalovirus immediate-early promoter and
enhancer.
RNA extraction and Northern analysis. Total RNA was extracted from
BHK-21 or S11E cells by the guanidinium-acid phenol method, as described by
Chomczynski and Sacchi (4). RNA was treated with a mixture of 1 M glyoxal and
50% (vol/vol) dimethyl sulfoxide at 50°C for 30 min (7). Glyoxalated RNA was
then separated on 1% agarose gels in circulating 10 mM sodium phosphate
buffer (pH 6.8). A 1-kb ladder (Gibco BRL) and l HindIII were 59 end labeled
with [g-32P]dATP, glyoxalated, and loaded onto the gels as the size standards.
RNAs on gels were transferred to charged nylon membranes (Amersham Phar-
macia Biotech, Arlington Heights, Ill.). The membranes were UV cross-linked
and deglyoxalated at 80°C in 20 mM Tris-HCl (pH 8). Prehybridization and
hybridization were carried out at 65°C in 0.5 M K2HPO4 (pH 6.8) containing 7%
sodium dodecyl sulfate (SDS) and 1% bovine serum albumin. The probes were
generated by the random-priming method with [a-32P]dCTP with the templates
generated by PCR of viral genomic DNA. The membranes were then washed at
65°C with 40 mM sodium phosphate (pH 6.8) containing 5% SDS and 0.5%
bovine serum albumin, followed by washing with 40 mM sodium phosphate (pH
6.8) containing 0.5% SDS. Radioactivity was detected and quantitated with a
STORM imaging system (Molecular Dynamics, Sunnyvale, Calif.). Before rehy-
bridization with a different probe, the membranes were stripped at 80°C in 10
mM Tris-HCl (pH 8) containing 1% SDS.
Transfection. Transfection of S11E cells was carried out by electroporation.
S11E cells (107) and 10 mg of plasmid DNA were mixed in a cuvette (Bio-Rad,
Hercules, Calif.) and shocked in a Gene-Pulser II (Bio-Rad). To monitor trans-
fection efficiencies, 2 mg of plasmid pEGFP-C1 (Clontech, Palo Alto, Calif.) was
included in each transfection, and the percentage of cells expressing green
fluorescent protein was determined at 24 h posttransfection by fluorescent mi-
croscopy.
Western analysis. Cells were lysed in Laemmli buffer containing 0.25 M Tris-
HCl (pH 6.8), 2% SDS, 10% glycerol, 5% b-mercaptoethanol, and 0.002%
bromophenol blue. The lysates were heated to 95°C and subjected to electro-
phoresis on 10% polyacrylamide gels. The broad-range prestained protein stan-
dard (Bio-Rad) was also loaded onto the gels. Proteins on gels were electro-
transferred (Bio-Rad) onto nitrocellulose membranes (Amersham Pharmacia
Biotech). The membranes were blocked in phosphate-buffered saline (PBS) plus
0.1% Tween 20 and 5% milk, incubated with the rabbit hyperimmune serum
against MHV-68-infected rabbit cells (36), washed in PBS containing 0.1%
Tween 20, and incubated with antirabbit immunoglobulin G conjugated with
horseradish peroxidase. The proteins were detected with the enhanced chemi-
luminescence detection ECL1PLUS system (Amersham Pharmacia Biotech),
and the signals were imaged with a STORM imaging system (Molecular Dynam-
ics).
DNA extraction and Southern analysis. Total DNA was harvested by lysing
cells in the buffer containing 10 mM Tris-HCl (pH 8), 50 mM EDTA (pH 8), and
0.5% SDS. The lysates were incubated with proteinase K (100 mg/ml) at 50°C
overnight and then extracted twice with phenol-chloroform (1:1). DNA was
precipitated with ammonium acetate and ethanol, and the DNA pellet was
dissolved in Tris-EDTA buffer (pH 8). Total DNA was subjected to restriction
enzyme digestion overnight and electrophoresed on 0.8% agarose gels. Gels
were stained with ethidium bromide to visualize DNA and then subjected to
depurination, denaturation, and neutralization. DNAs on treated gels were
transferred to charged nylon membranes (Amersham Pharmacia Biotech). The
membranes were UV cross-linked and prehybridized at 68°C in the buffer con-
taining 53 SSC (13 SSC is 0.15 M NaCl plus 0.015 M sodium citrate), 103
Denhardt’s solution, 0.5% SDS, and denatured salmon sperm DNA (50 mg/ml).
Probes were generated by the random priming method using [a-32P]dCTP and
PCR products of genomic viral DNA as templates. The membranes were washed
at 68°C in 23 SSC with 0.1% SDS, followed by 0.13 SSC with 0.1% SDS.
Radioactivity was detected and quantitated by using a STORM imaging system
(Molecular Dynamics).
RESULTS
The structure of the rta gene. MHV-68 ORF50 was previ-
ously shown to share homology to ORF50 of HHV-8, EBV,
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and HVS (18, 40). The genomic location of ORF50 is shown in
Fig. 1A. ORF50 encodes the major portion of the rta homo-
logue of gammaherpesviruses. The rta genes of HHV-8, EBV,
HVS, and BHV-4 share one common feature: the second exon
containing ORF50 is spliced to the first exon by removing an
intron carrying ORF49 (17, 19, 35, 39, 41). Because of the
conservation of the splicing event, we hypothesized that the rta
gene of MHV-68 undergoes similar RNA processing. To con-
firm this, total RNA was isolated from MHV-68-infected
BHK-21 cells and reverse transcribed with oligo(dT), followed
by PCR, with primers flanking ORF50 (R3 and R4). The
resultant RT-PCR product was ;1.7 kb and smaller than the
PCR product (2.6 kb) generated with the same pair of primers,
but with genomic DNA as the template, consistent with RNA
splicing (data not shown). To precisely determine the splicing
junction, the RT-PCR product was reamplified with primer R3
and another primer, R6 (internal to R4), and then cloned and
sequenced with the R7 primer. As shown in Fig. 1B, the splic-
ing donor and acceptor sites are located at nt 66795 and 67661,
respectively (numbering according to the National Center for
Biotechnology Information database [40]). The sequences
flanking nt 66795 and 67661 were highly homologous to the
consensus sequences flanking the splice donor and acceptor
sites, respectively. As a result of splicing, an 866-nt intron
containing the entire ORF49 was removed (Fig. 1C). Instead
of the predicted methionine of ORF50 (40), the translation
initiation methionine of MHV-68 rta would be located in the 59
small exon at nt 66760. Consequently, MHV-68 Rta would
have an extra 94 amino acids (aa) added to the N terminus of
ORF50 (489 aa).
MHV-68 rta was expressed as an immediate-early tran-
script. To examine the kinetics of MHV-68 rta transcription
during de novo infection, BHK-21 cells were infected at 5
PFU/cell, and total RNA was harvested at different times
postinfection. In addition, infections were carried out in the
presence of 100 or 200 mg of cycloheximide per ml (a protein
synthesis inhibitor) or 200 mg of PAA per ml (a herpesvirus
DNA polymerase inhibitor). The rta transcripts were analyzed
by Northern blotting with the 0.7-kb PCR fragment spanning
the C terminus of ORF50 (corresponding to nt 68651 to 69378;
Fig. 1C) as a probe. As shown in Fig. 2A, a major band of 2.0
kb was detected at the earliest time point, 2 h postinfection
(Fig. 2A, lane 4). Expression of the 2-kb transcript peaked at
4 h postinfection (Fig. 2A, lane 5) and decreased at 8 h postin-
fection (Fig. 2A, lane 6). In the presence of cycloheximide, the
2-kb transcript was still detected (Fig. 2A, lanes 7 and 8),
consistent with the expression pattern of an immediate-early
gene.
A single-stranded RNA probe was used for Northern anal-
ysis (data not shown) and confirmed that the orientation of the
2-kb transcript was the same as that of ORF50. This 2.0-kb
transcript would be large enough to encode the entire ORF of
Rta (583 aa). The 0.7-kb probe also detected a few minor
larger transcripts, one of which was deduced to be 3.4 kb and
only appeared in the cells treated with cycloheximide (Fig. 2A,
lanes 7 and 8). Other transcripts appeared later than the major
2-kb transcript, and their expression was abolished in the pres-
ence of cycloheximide (Fig. 2A, lanes 7 and 8), as well as in the
presence of PAA (Fig. 2A, lane 11), indicating that they were
late viral transcripts.
The same membrane was stripped and rehybridized with a
probe derived from the thymidine kinase (TK) ORF (Fig. 2B).
Several transcripts were detected, with three predominant spe-
cies of 2.1, 2.6, and 3.8 kb. The major 2.6-kb species was
detected at 2 h postinfection (Fig. 2B, lane 2) and was ex-
pressed earlier than the other species of 2.1, 2.8, 3.2, and 3.8
kb, but disappeared at 8 h postinfection (Fig. 2B, lane 6). Its
expression, however, was sensitive to cycloheximide treatment
(Fig. 2B, lanes 7 and 8), indicating that this was an early viral
transcript. The minor 3.2-kb species was expressed at kinetics
similar to those of the major 2.6-kb transcript and was also an
early viral transcript. Other species of transcripts, including the
other major 2.1- and 3.8-kb transcripts, continued to accumu-
late until 13 h postinfection and then decreased at 24 h postin-
fection. However, their expression was inhibited by the pres-
ence of PAA (Fig. 2B, lane 11), leading to the conclusion that
the other species were late viral transcripts. Our results are
consistent with a previous study in which several TK-related
transcripts were detected, including a 2.6-kb transcript, and the
expression pattern of this 2.6-kb transcript was characteristic of
an early gene (26).
The membrane was rehybridized with a probe derived from
the M9 ORF (Fig. 2C). MHV-68 M9 has homology to ORF65
of HHV-8 (40), which encodes a capsid protein. Several spe-
cies of RNAs were detected, including two major transcripts of
0.9 and 3.6 kb, which were observed at 4 h postinfection,
FIG. 1. Structure of the MHV-68 rta gene. (A) Genomic location of ORF50.
The nucleotide numbers are assigned on the basis of the MHV-68 sequence in
the National Center for Biotechnology Information database (40). The open
boxes represent ORFs predicted by computer analysis, and the numbers assigned
to individual ORFs are based on homology with the corresponding ORFs of
HVS and HHV-8 (40). The arrows in the open boxes indicate the orientation of
ORFs. A major portion of the rta gene is carried by ORF50. Downstream of
ORF50 is ORFM7 encoding gp150, which shares homology with EBV gp350
(34). (B) Sequencing analysis of the rta cDNA. RNA harvested from BHK-21
cells infected with MHV-68 at 2 PFU/cell was reverse transcribed with oligo(dT)
and amplified, first by primers R3 and R4 and then by primers R3 and R6. The
resultant product was cloned, and the positive clone was sequenced with the R7
primer. The splice donor and acceptor sites were mapped to nt 66795 and 67661,
respectively. (C) Splicing of the rta gene. The splice donor (s.d.) and splice
acceptor (s.a.) sites were localized to nt 66795 and 67661, respectively. An intron
of 866 nt is removed, and two exons are joined together to generate the Rta
ORF, with the translation initiation codon at nt 66760. Primers R3 and R4 were
used for PCR amplification of the cDNA product and the genomic sequence
spanning the rta gene. R3 and R6 were used to reamplify the cDNA PCR
product of R3 and R4 for cloning. R7 was used to sequence the splicing junction.
The probe shown in panel C was used for Northern analysis of the rta transcripts
shown in Fig. 2A.
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gradually increased until 13 h postinfection and then declined
by 24 h postinfection. Their expression was abrogated by treat-
ment with PAA (Fig. 2C, lane 11), indicating that they were
late viral transcripts. Two minor transcripts of 2.8 and 2.9 kb
were also observed. The 2.8-kb RNA was detected at 4 h and
disappeared at 24 h postinfection, and the 2.9-kb RNA was not
visible until 8 h, and continued to accumulate until 13 h post-
infection. Expression of both RNAs was sensitive to the pres-
ence of PAA (Fig. 2C, lane 11), indicating that, like the two
major transcripts, these two minor transcripts were late viral
RNAs.
MHV-68 Rta activated viral lytic gene expression in latently
infected S11E cells. To study the function of MHV-68 Rta, the
2.6-kb sequence (nt 66760 to 69373) spanning the initiation
methionine and the termination codon was cloned into a eu-
karyotic gene expression vector, pcDNA3, where expression
was driven by the cytomegalovirus immediate-early promoter.
Since rta was expressed as an immediate-early gene during
de novo lytic infection, we tested whether Rta could disrupt
latency and initiate the cascade of lytic gene expression.
pcDNA3/MHV-68 rta was transfected into an MHV-68 la-
tently infected B-cell line, S11E, and transfection efficiency was
determined by the percentage of cells expressing green fluo-
rescent protein encoded by a cotransfected plasmid, ranging
from 5 to 10%.
Transfected S11E cells were harvested at different times
posttransfection for Western analyses by using the rabbit hy-
perimmune serum raised against MHV-68-infected rabbit cell
lysates, and the results are shown in Fig. 3. Transfection of
pcDNA3/MHV-68 rta (Fig. 3A) into S11E cells induced the
expression of a variety of proteins, which were also seen in
FIG. 2. MHV-68 rta is expressed as an immediate-early gene. Infection was
carried out in six-well plates, and RNA was harvested at various times postin-
fection (p.i.), as indicated at the top of the panels. Half of the total cellular RNA
was glyoxalated and subjected to Northern analysis. In each panel, lanes 1 and 2
are a 1-kb DNA ladder and l HindIII, respectively; the sizes of the individual
bands are indicated to the left. RNA was collected at 0 (lane 3), 2 (lane 4), 4 (lane
5), or 13 (lane 9) h postinfection. RNA was harvested from cells at 8 h postin-
fection without (lane 6 [N]) or with cycloheximide treatment at 100 (lane 7 [C1])
or 200 (lane 8 [C2]) mg/ml. At 24 h postinfection, RNA was isolated from cells
without (lane 10 [N]) or with (lane 11) 200 mg of PAA per ml added to the
medium. The same membrane was hybridized with three different probes, as
shown in the three panels. The probe used in panel A was derived from the very
last 0.7-kb sequence (nt 68651 to 69378) or ORF50, which was generated by SacI
digestion of the PCR product amplified with the R3 and R4 primers. Panel B
shows the image of the membrane rehybridized with the probe derived from the
PCR product spanning the 1.9-kb TK ORF (nt 32879 to 34813). The probe used
in panel C was derived from the PCR product of the 0.5-kb M9 ORF (nt 93962
to 94522). The deduced sizes of the transcripts are indicated to the right of each
panel. Radioactivity was detected with a STORM imaging system.
FIG. 3. Induction of viral lytic proteins by Rta. S11E cells (107) were elec-
troporated with pcDNA3/MHV-68 rta (A) or pcDNA3 (B). Total protein from
105 cells was collected at 12 (lanes 4 of panels A and B), 24 (lanes 5 of panels A
and B), or 48 (lanes 6 of panels A and B) h posttransfection (p.t.). Proteins from
104 uninfected (UI [lane 1]) or MHV-68-infected (I [lane 2]) BHK-21 cells or
from 105 untransfected S11E cells (UT [lanes 3]) were loaded and subjected to
Western analysis with the rabbit hyperimmune serum against MHV-68-infected
rabbit cell lysates. The molecular masses (kilodaltons) of individual proteins in
the marker are indicated to the left.
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lytically infected BHK-21 cells (Fig. 3A, lane 2). Expression of
most proteins peaked at 24 h posttransfection, although some
proteins were visible as early as 12 h posttransfection. No viral
lytic proteins were detected in pcDNA3-transfected S11E cells
at any time posttransfection (Fig. 3B). Because 105 S11E cells
with a 10% transfection efficiency were loaded in each lane
(Fig. 3A, lanes 4 to 6), we found that much stronger signals
were detected in a similar number of infected BHK-21 cells
(104) in the control (Fig. 3A, lane 2), indicating higher levels
of lytic protein expression in these cells. It was also noted
that one lytic protein (Fig. 3A, indicated with an asterisk)
was expressed at high levels in infected BHK-21 cells, but
was not detected in S11E cells transfected with pcDNA3/
MHV-68 rta.
Northern analyses were also performed to examine lytic
gene transcription in transfected S11E cells. The kinetics of TK
and M9 gene expression after Rta transfection are shown in
Fig. 4. As described earlier, five major TK-related transcripts
were seen in lytically infected BHK-21 cells (Fig. 2B), and a
similar pattern of TK transcripts was also detected in S11E
cells transfected with pcDNA3/MHV-68 rta (Fig. 4A, lanes 6 to
9), but not in cells transfected with pcDNA3 (Fig. 4A, lanes 2
to 5). The 2.6- and 3.2-kb transcripts expressed as early tran-
scripts in lytically infected BHK-21 cells (Fig. 2B) were in-
duced to a high level as early as 12 h posttransfection, and their
expression decreased at 24 h posttransfection. The other TK-
related RNAs, expressed as late viral transcripts in lytically
infected BHK-21 cells (Fig. 2B), were visible at 12 h posttrans-
fection, but continued to accumulate until 24 h posttransfec-
tion.
The same membrane was stripped and rehybridized with the
M9 ORF probe (Fig. 4B). In lytically infected BHK-21 cells,
the major 0.9- and 3.6-kb M9 transcripts were expressed as
late viral RNAs (Fig. 2C). As seen in Fig. 4B, transfection of
pcDNA3/MHV-68 rta (Fig. 4B, lanes 6 to 9), but not of
pcDNA3 (Fig. 4B, lanes 2 to 5), led to expression of 0.9- and
3.6-kb M9 transcripts in S11E cells. The transcripts accumu-
lated to high levels at 24 h posttransfection. Two minor M9
RNAs seen in lytically infected BHK-21 cells were, however,
only detected at very low levels in S11E cells transfected with
pcDNA3/MHV-68 rta.
MHV-68 Rta induced viral DNA replication in latently in-
fected S11E cells. Since transfection of pcDNA3/MHV-68 rta
activated some late viral transcripts, such as those of M9, the
expression of which was demonstrated earlier to be dependent
on viral DNA replication in lytically infected BHK-21 cells
(Fig. 2C, lanes 10 and 11), viral DNA replication might also
have been induced in S11E cells transfected with pcDNA3/
MHV-68 rta. To confirm this, viral DNA replication was ana-
lyzed by Southern blotting. As seen in Fig. 5, viral DNA in
S11E cells was greatly amplified by transfection of pcDNA3/
MHV-68 rta (lanes 6 to 8), but not by pcDNA3 (lanes 3 to 5).
At 24 h posttransfection, a 90-fold increase in the amount of
viral DNA in pcDNA3/MHV-68 rta-transfected cells was de-
tected compared to the amount in untransfected cells (Fig. 5,
lanes 2 and 6). Given that the transfection efficiency was 10%,
this would be an average of 900-fold induction of viral DNA
synthesis in each transfected cell.
To confirm that the increase in viral DNA by Rta transfec-
tion was due to the induction of viral lytic DNA replication
rather than amplification of the viral latent genome, a terminal
repeat assay (31) was performed. The linear MHV-68 genome
has multiple 1.2-kb tandem repeats at each terminus. In la-
tently infected S11E cells, the MHV-68 genome exists as an
episomal circular DNA generated by fusion through the ter-
FIG. 4. Activation of viral lytic gene expression by Rta. RNA from S11E cells
electroporated with pcDNA3 (lanes 2 to 5) or pcDNA3/MHV-68 rta (lanes 6 to
9) was collected at 12 (lanes 2 and 6), 24 (lanes 3 and 7), 36 (lanes 4 and 8), or
48 (lanes 5 and 9) h posttransfection (p.t.). Half of the total cellular RNA was
glyoxalated and subjected to Northern analysis. The same membrane hybridized
with different probes is shown in two panels. The probe used in panel A is
derived from the TK ORF (as in Fig. 1B). In panel B, the probe is derived from
the M9 ORF (as in Fig. 1C). Lane 1 is a 1-kb DNA ladder, with the sizes of
individual bands indicated to the left. The deduced sizes of transcripts are
indicated to the right. Radioactivity was detected with a STORM imaging system.
FIG. 5. Amplification of viral DNA by Rta. Total DNA from 2 3 106 S11E
cells transfected with pcDNA3 (lanes 3 to 5) or pcDNA3/MHV-68 rta (lanes 6 to
8) was harvested at 24 (lanes 3 and 6), 48 (lanes 4 and 7), or 72 (lanes 5 and 8)
h posttransfection (p.t.) and subjected to digestion with HindIII. The digested
DNAs were electrophoresed on a 0.7% agarose gel for Southern analysis.
HindIII-digested DNA from 5 3 105 MHV-68-infected BHK-21 cells was loaded
in lane 1 as a positive control (I), and digested DNA from 2 3 106 untransfected
S11E cells was loaded in lane 2 as a negative control (UT). The probe used to
detect the viral DNA was derived from the 6.2-kb PCR product (nt 51 to 6298)
spanning the far left end of the viral genome. Based on the sequence (40), a
6.2-kb DNA fragment would be detected with the probe. Radioactivity was
detected and quantitated with a STORM imaging system.
VOL. 74, 2000 MURINE GAMMAHERPESVIRUS 68 REACTIVATION 3663
mini of the linear form (38). As illustrated in Fig. 6A, the
terminal repeat assay is based on the fact that herpesviral DNA
is replicated via a rolling-circle mechanism during the lytic
cycle. Monomers of viral genomic DNA with variable numbers
of terminal repeats are produced as a result of DNA cleavage
at any one of the terminal repeats between monomeric viral
genomes on concatemers. After digestion of viral DNA with
HindIII (not present in the repeat) and probing with a unique
region adjacent to terminal repeats, a 1.2-kb ladder of DNA
fragments would be generated, due to variable numbers of
repeats at the terminus. If lytic replication does not occur, after
digestion of circular viral DNA, a single large DNA fragment
containing the fused termini that harbors multiple copies of
terminal repeats would be detected on Southern blots. The
results of the terminal repeat assay are shown in Fig. 6B. Since
viral DNA was greatly increased by Rta at 24 h posttransfec-
tion (Fig. 5), DNA was harvested at an additional time point at
12 h posttransfection. In S11E cells transfected with pcDNA3,
only a large DNA fragment ($23 kb) was detected at all time
points (Fig. 6B, lanes 2 to 5), indicating that lytic replication
did not occur. However, the DNA of cells transfected with
pcDNA3/MHV-68 rta gave rise to ladders similar to those seen
in lytically infected BHK-21 cells (Fig. 6B, lane 1). The inten-
sity of DNA laddering was increased between 12 and 24 h
posttransfection and then declined. These results provide evi-
dence that transfection of Rta induced lytic replication of viral
DNA and processing of the replicated viral DNA.
MHV-68 Rta transfection led to production of infectious
viral particles from latently infected S11E cells. We have
shown that introduction of MHV-68 Rta into S11E cells acti-
vated viral lytic gene expression and DNA replication. We
further tested whether Rta was sufficient to drive the viral lytic
cycle to production of viruses. The supernatants from trans-
fected S11E cells were collected at various time points, and
the viral titers were measured by plaque assays. The results
are shown in Fig. 7. The viral titers in the supernatants from
Rta-transfected S11E cells were much higher than in those
from pcDNA3-transfected S11E cells. At 48 h posttransfection,
there were ;130-fold more infectious viruses in the superna-
tant from Rta-transfected S11E cells.
DISCUSSION
Previous studies have shown the central roles of HHV-8 or
EBV Rta in the switch from viral latency to lytic replication.
Since the rta gene is highly conserved among gammaherpes-
viruses, we studied the gene expression and functions of
MHV-68 rta in cell cultures. MHV-68 rta was expressed as an
immediate-early gene during de novo lytic infection of BHK-21
FIG. 6. Induction of lytic replication and processing of viral DNA by Rta. (A) The basis of the terminal repeat assay. The solid lines represent the double-stranded
viral genome, and the boxes represent terminal repeats. In panel A, a rolling-circle mechanism is illustrated at the top, and the right ends of monomeric viral genomes
after DNA processing are shown at the bottom. Since DNA processing can occur at any one of the terminal repeats between monomeric viral genomes on concatemers,
there will be various numbers of repeats, with as few as one, at the termini of monomeric viral genomes. The gray arrow and dotted line indicate where digestions of
HindIII occur adjacent to the terminal repeats. The shaded box indicates the position of the probe used for panel B. The details are further described in the text. (B)
The results of the terminal repeat assay. Total DNA from 106 S11E cells transfected with pcDNA3 (lanes 2 to 5) or pcDNA3/MHV-68 rta (lanes 6 to 9) was harvested
at 12 (lanes 2 and 6), 24 (lanes 3 and 7), 36 (lanes 4 and 8), or 48 (lanes 5 and 9) h posttransfection (p.t.). DNA was digested with HindIII and subjected to Southern
analysis with a probe (its relative position is indicated in panel A) derived from a 0.8-kb PCR product (nt 118314 to 117560). Lane 1 is the positive control from the
DNA of 105 MHV-68-infected BHK-21 cells digested with HindIII (I). Indicated to the left are the sizes of individual bands in a 1-kb DNA ladder. Radioactivity was
detected with a STORM imaging system.
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cells. Furthermore, exogenous expression of Rta activated the
virus from latency in S11E cells harboring latent MHV-68. Our
results have provided a foundation for studying the molecular
mechanisms controlling establishment, maintenance, and dis-
ruption of latency in vivo.
Our analysis of the MHV-68 rta gene demonstrates that an
866-nt intron containing the entire ORF49 is spliced, generat-
ing the Rta ORF of 583 aa with the initiation methionine at nt
66760 (Fig. 1). 59 rapid amplification of cDNA ends was also
carried out on the polyadenylated RNA, and the preliminary
data localized the 59 end of the rta transcript at ;100 nt
upstream of the initiation methionine of the Rta ORF (data
not shown). Taken together with a consensus poly(A) signal
located 57 nt after the termination codon, the size of the
spliced rta RNA is estimated to be ;1.9 kb, consistent with the
size of the major immediate-early rta transcript (2 kb) detected
in lytically infected BHK-21 cells (Fig. 2A). However, the na-
ture of the other minor transcripts requires further investiga-
tion.
The rta genes of gammaherpesviruses share similarities in
the genomic location, amino acid sequence, and splicing pat-
tern, which suggests that Rta plays a conserved and important
role in the life cycle of the virus. However, among gammaher-
pesviruses, there are differences in terms of the location of the
initiation methionine and the nature of the rta transcript. Ex-
cept for EBV (19), the initiation methionines of Rta in MHV-
68, HHV-8 (17, 35), HVS (42), and BHV-4 (39) are located in
the first rather than the second exon. Thus, EBV Rta is entirely
encoded by ORF50 (19), whereas the Rta proteins of the other
gammaherpesviruses have extra amino acids added to the N
terminus of ORF50. The rta transcripts of MHV-68, HVS, and
BHV-4 are monocistronic (39, 41), whereas the EBV rta tran-
script is bicistronic, with an additional ORF encoding ZEBRA
downstream of the rta ORF (19). The HHV-8 rta transcript
is polycistronic, with not only the K8 ORF encoding the
ZEBRA homologue (10, 16, 17, 35, 46), but also the puta-
tive K8.2 ORF downstream of the K8 ORF (46). It is not
clear whether ZEBRA of EBV or HHV-8 can be translat-
ed from either the bicistronic or polycistronic message. No
ZEBRA homologue has been identified in MHV-68, HVS,
or BHV-4.
MHV-68 Rta most likely functions as a transcriptional acti-
vator. Homologues of Rta from other gammaherpesviruses
such as EBV, HVS, and BHV-4 have been shown to activate
the promoters of viral early genes in transient transfection
assays (1, 9, 11, 12, 24, 39). Amino acid sequence alignments of
the Rta homologues reveal that the most conserved region is at
the N terminus. This conserved portion of EBV Rta is required
for dimerization and DNA binding (20). Another well-con-
served region is at the C terminus and is rich in acidic residues,
which is characteristic of activation domains of many transcrip-
tional activators. It has been shown that this region of EBV
Rta is essential for transcriptional activation (20). Therefore,
the Rta homologues of gammaherpesviruses share similar
amino acid sequences and may also have similar functions in
activating viral and possibly cellular promoters. However, it is
not clear whether the Rta proteins are capable of substituting
for each other to transactivate virus-specific promoters. It has
been shown that BHV-4 Rta could not transactivate the viral
promoters that were activated by either HVS or EBV Rta, nor
could EBV Rta transactivate the viral promoters that were
activated by either BHV-4 or HVS Rta (39). This specificity
suggests that despite the conservation of the functions in trans-
activation, virus- or host-specific interactions may be involved
in mediating such functions.
MHV-68 Rta alone was sufficient to reactivate the virus in B
cells. Transfection of an Rta expression plasmid induced the
expression of early and late viral RNAs and proteins, activated
lytic replication of viral DNA, and led to the production and
release of infectious viral particles. So far, no other reports
have demonstrated that Rta alone is sufficient to drive the
progression of the viral lytic cycle to the production of infec-
tious virions. In our time course experiments (Fig. 4), the lytic
gene expression induced by Rta in S11E cells proceeded in a
cascade similar to that observed in de novo lytic infection of
BHK-21 cells (Fig. 2). After Rta transfection, the early 2.6-kb
TK transcript was expressed to a high level at 12 h posttrans-
fection, followed by the late 0.9- and 3.6-kb M9 transcripts,
peaking at 24 h posttransfection (Fig. 4). The highest level of
viral DNA was observed at 24 h posttransfection (Fig. 5 and 6),
followed by the maximal accumulation of infectious particles in
the supernatants occurring at 36 h posttransfection (Fig. 7).
Nevertheless, we noticed that there was significantly more in-
tensive viral lytic replication in de novo-infected BHK-21 cells
than in S11E cells transfected by pcDNA3/MHV-68 rta. Dif-
ferences in the replication levels between the two cell types
may be due to a suboptimal microenvironment in B cells for
viral lytic replication. This interpretation is consistent with the
predominantly latent nature of B-cell infection. We also ob-
served that one major lytic viral protein expressed in de novo-
infected BHK-21 cells was not seen in S11E cells transfected by
pcDNA3/MHV-68 rta. Because the antibody used for Western
analysis is polyclonal, the identity of this viral protein is not
clear. However, since there are infectious particles produced
and released into the medium, the viral protein not detected in
Rta-induced reactivation is unlikely to be essential for viral
replication in B cells.
Based on our results that rta was expressed as an immediate-
early gene during de novo lytic infection and that transfection
of an Rta expression plasmid induced the viral lytic cycle in
latently infected B cells, we propose a working model for the
functions of MHV-68 Rta. In this model, Rta is the central
viral factor determining lytic replication or latency of MHV-68.
During de novo infection of permissive cells such as BHK-21,
Rta, presumably activated by cooperation between a virion
protein similar to HSV VP16 and cellular transcription factors,
is expressed to drive the viral lytic cycle. In nonpermissive cells
FIG. 7. Production and release of infectious viruses induced by Rta. At the
times indicated at the bottom of the diagram, 10 ml of suspension cultures of
S11E cells transfected with pcDNA3 (squares) or pcDNA/MHV-68 rta (dia-
monds) was centrifuged twice to remove cells, and the supernatants were col-
lected for plaque assays to measure the viral titers. The data, including standard
deviations indicated with error bars, were obtained from two or three indepen-
dent assays and are expressed as PFU per milliliter of supernatant.
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such as B cells, Rta expression is blocked, which prevents
initiation of the viral lytic cascade, leading to latency. Sus-
tained latency may require expression of viral latent genes.
However, in response to certain stimuli, Rta expression is
either activated or derepressed, and then latency is disrupted
and the virus undergoes reactivation. This model strongly
points to regulation of Rta expression governing the balance
between viral latency and lytic replication. Moreover, control-
ling the expression of Rta may allow us to tip the balance
between latency and lytic replication. Therefore, MHV-68 of-
fers a unique model system in which to study the consequences
of such a balance to viral pathogenesis.
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